Vuja De Sciences: Funding, Investors & Team (Sep 2026)
Vuja De Sciences creates treatments for cancer metastasis that aim to stop cancer from spreading and coming back. They use advanced laboratory technologies for testing on metastatic conditions, along with Comparative Oncology to reduce risks in product development and increase the chances of successful clinical trials in human cancer treatment. The strategies they use for maintaining and supporting cancer therapy target the same mechanisms that are effective for primary tumors and large metastatic tumors.
Vuja De Sciences has raised $700k across 1 funding round on record, the most recent an undisclosed round of $700k announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vuja De Sciences Company Profile and Key Stats
Latest funding round on record: May 2024.
Vuja De Sciences Funding Rounds
Vuja De Sciences Founders and Leadership Team
No contact details are on record for this team yet.
Vuja De Sciences Funding Compared to Other Biotechnology Startups
Vuja De Sciences' latest round of $700k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vuja De Sciences in Biotechnology and Hoboken
Companies Similar to Vuja De Sciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Vuja De Sciences Funding FAQs
What does Vuja De Sciences do?
Vuja De Sciences creates treatments for cancer metastasis that aim to stop cancer from spreading and coming back. They use advanced laboratory technologies for testing on metastatic conditions, along with Comparative Oncology to reduce risks in product development and increase the chances of successful clinical trials in human cancer treatment. The strategies they use for maintaining and supporting cancer therapy target the same mechanisms that are effective for primary tumors and large metastatic tumors.
How much funding has Vuja De Sciences raised?
Vuja De Sciences has raised $700k across 1 round on record. The most recent is an undisclosed round of $700k announced in May 2024.
When did Vuja De Sciences last raise funding?
Vuja De Sciences' most recent funding round on record is an undisclosed round of $700k, announced in May 2024.
Who founded Vuja De Sciences?
FundedIQ lists Robert E Hurst (Founder) at Vuja De Sciences.
Where is Vuja De Sciences headquartered?
Vuja De Sciences is based in Hoboken, New Jersey, United States.
How many employees does Vuja De Sciences have?
Vuja De Sciences is in the 1-10 employee band.
How does Vuja De Sciences' funding compare to other Biotechnology startups?
Vuja De Sciences' latest round of $700k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Vuja De Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vuja De Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.